Watchlist Price Alert

Tango Therapeutics Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

1.86

-0.00 (-0.27%)

At close: May 23, 2025, 3:59 PM

1.90

1.88%

After-hours: May 23, 2025, 05:49 PM EDT

-0.27% (1D)

Bid	1.69
Market Cap	202.15M
Revenue (ttm)	40.99M
Net Income (ttm)	-132.26M
EPS (ttm)	-1.2
PE Ratio (ttm)	-1.55
Forward PE	-1.42
Analyst	Buy

Ask	1.92
Volume	2,308,167
Avg. Volume (20D)	1,399,061
Open	1.83
Previous Close	1.86
Day's Range	1.79 - 2.04
52-Week Range	1.03 - 12.02
Beta	1.03

About TNGX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol TNGX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TNGX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

6 months ago

-37.45%

Tango Therapeutics shares are trading lower after ... Unlock content with Pro Subscription

News

1 week ago · zacks.com

Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Lags Revenue Estimates

Tango Therapeutics, Inc. (TNGX) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.35 per share a year ago.

2 weeks ago · zacks.com

Tango Therapeutics, Inc. (TNGX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Tango Therapeutics (TNGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago · zacks.com

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates

Tango Therapeutics, Inc. (TNGX) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.32 per share a year ago.